1. IMS Institute for Healthcare Informatics Declining medicine use and costs: for better or worse? A review of the use of medicines in the United States in 2012 http://static.correofarmaceutico.com/docs/2013/05/20/usareport.pdf 2013
2. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability;Schuirmann;J. Pharmacokinet. Biopharm.,1987
3. US Food and Drug Administration Center for Drug Evaluation and Research Orange book - Approved drug products with therapeutic equivalence evaluations, section 1.3 Statistical Criteria for Bioequivalence, 33rd ed http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/UCM071436.pdf 2013
4. US Food and Drug Administration April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee: Topic 1, Revising the BE approaches for critical dose drugs http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinical Pharmacology/ucm209318.htm 2010
5. US Food and Drug Administration Draft guidance on warfarin sodium http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM201283.pdf 2012